COMMUNIQUÉS West-GlobeNewswire

The Ensign Group Declares Quarterly Dividend of $0.045 Per Share

18/06/2018 - 22:30

MISSION VIEJO, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]

K2M Group Holdings, Inc. to Participate in JMP Securities 2018 Life Science Conference

18/06/2018 - 22:30

LEESBURG, Va., June 18, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]

ESPERITE (ESP) further delays publication of Annual Report 2017.

18/06/2018 - 22:25

Amsterdam, The Netherlands - 18 June 2018 Esperite regrets to announce that due remaining technical issues as reported before and despite the constant efforts provided by the different teams involved, additional time is [...]

Viveve Reports Positive Six-Month Data from Stress Urinary Incontinence Feasibility Study

18/06/2018 - 22:13

83% of women treated experienced an improvement in one-hour pad weight with an overall mean improvement of 73% Clinically meaningful benefit achieved across all quality of life outcome measures Company to host [...]

Veritas Pharma Signs R&D and Medical Cannabis Supply Agreement with Colombian Producer Foliumed S.A.S.

18/06/2018 - 22:05

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) , (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of [...]

Quotient Limited to Host Investor Day on July 16, 2018

18/06/2018 - 22:05

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July 16, 2018 from 9:00am [...]

Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer

18/06/2018 - 22:05

SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine [...]

ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates

18/06/2018 - 22:01

Conference Call and Live Audio Webcast Scheduled for June 25, 2018, 4:30 p.m. ET EDISON, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the [...]

PSI Named Among Computerworld’s Best Places to Work in IT for Third Year in a Row

18/06/2018 - 20:55

ARLINGTON, Va., June 18, 2018 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI), a leading provider of information technology (IT) solutions and services for the federal government, is pleased to announce [...]

INSYS Therapeutics Provides an Update on Its Ongoing Transformation

18/06/2018 - 18:58

PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reiterated its [...]

Burcon Announces Fiscal 2018 Results and Reviews Operations

18/06/2018 - 18:57

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX:BU), a leader in natural product extraction, purification and isolation technologies, reported results for the year [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

18/06/2018 - 18:28

Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 18 juin 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

CROSSJECT : Descriptif du programme de rachat d'actions 2018-2019

18/06/2018 - 18:20

Communiqué de Presse Descriptif du programme de rachat d'actions 2018-2019 Dijon, le 18 juin 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un [...]

Sanofi: Disclosure of trading in own shares

18/06/2018 - 18:01

Attachment Disclosure of trading in own shares.pdf

Sanofi : Déclaration des transactions sur actions propres

18/06/2018 - 18:01

Pièce jointe Déclaration des transactions sur actions propres.pdf

Ossur Hf : Transactions in relation to share buyback program

18/06/2018 - 18:01

Announcement no. 40/2018 Reykjavik, 18 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab in Patients with Multiple Sclerosis at the 4th Congress of the European Academy of Neurology

18/06/2018 - 18:00

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced updated results from the Phase 2 multicenter trial of ublituximab (TG-1101), the Company’s novel glycoengineered anti-CD20 [...]

GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018

18/06/2018 - 17:49

GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018 Lille (France), Cambridge (Massachusetts, United States), June 18, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a [...]

GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018

18/06/2018 - 17:49

GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018 Lille (France), Cambridge (Massachusetts, Etats-Unis), le 18 juin 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société [...]